SWedish Intensive Care Biobank

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUppsala University

About this trial

The goal of this observational study is to understand the genetic and molecular risk factors for developing critical illness in adult intensive care unit (ICU) patients in Sweden. The main questions it aims to answer are:

Which genetic variants are associated with increased risk of critical illness from conditions such as infections, sepsis, and organ failure?

Can circulating proteins and metabolites mediate the effect of genetic risk factors on the severity of illness?

Participants will:

Provide blood samples at ICU admission and again 3-6 months after discharge Consent to genetic analysis and data linkage with national health registries

Have their ICU treatment and outcomes followed using registry and clinical data

This study aims to build a national infrastructure for rapid sample collection and analysis that can also support research in future pandemics.

Eligibility criteria

Qualifiers

Adults admitted to intensive care in Sweden

Disqualifiers

Non adults

Not admitted to intensive care

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

25,000 Participants
are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators